254 related articles for article (PubMed ID: 36622940)
1. Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria.
Beumer BR; van Vugt JLA; Sapisochin G; Yoon P; Bongini M; Lu D; Xu X; De Simone P; Pintore L; Golse N; Nowosad M; Bennet W; Tsochatzis E; Koutli E; Abbassi F; Claasen MPAW; Merli M; O'Rourke J; Gambato M; Benito A; Majumdar A; Tan EK; Ebadi M; Montano-Loza AJ; Berenguer M; Metselaar HJ; Polak WG; Mazzaferro V; IJzermans JNM;
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2373-2382. PubMed ID: 36622940
[TBL] [Abstract][Full Text] [Related]
2. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
3. Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.
Akce M; Liu Y; Zakka K; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT; Bilen MA; El-Rayes BF
Am J Clin Oncol; 2021 Feb; 44(2):74-81. PubMed ID: 33350681
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
[TBL] [Abstract][Full Text] [Related]
5. Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
Andreou A; Gül S; Pascher A; Schöning W; Al-Abadi H; Bahra M; Klein F; Denecke T; Strücker B; Puhl G; Pratschke J; Seehofer D
HPB (Oxford); 2015 Feb; 17(2):168-75. PubMed ID: 25263399
[TBL] [Abstract][Full Text] [Related]
6. Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma.
Yang JF; Huang WY; Lo CH; Lee MS; Lin CS; Shen PC; Dai YH; Wang YF; Chen TW
Sci Rep; 2022 Nov; 12(1):19100. PubMed ID: 36352042
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation.
Kuo SZ; Ahmad M; Dunn MA; Montano-Loza AJ; Carey EJ; Lin S; Moghe A; Chen HW; Ebadi M; Lai JC
Transplantation; 2019 Nov; 103(11):2312-2317. PubMed ID: 30985575
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
[TBL] [Abstract][Full Text] [Related]
9. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
14. European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis.
Anand A; Mohta S; Agarwal S; Sharma S; Gopi S; Gunjan D; Madhusudhan KS; Singh N; Saraya A
J Clin Exp Hepatol; 2022; 12(1):52-60. PubMed ID: 35068785
[TBL] [Abstract][Full Text] [Related]
15. Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis.
Keshoofi P; Schindler P; Rennebaum F; Cordes F; Morgul H; Wildgruber M; Heinzow HS; Pascher A; Schmidt HH; Hüsing-Kabar A; Praktiknjo M; Trebicka J; Seifert LL
BMC Gastroenterol; 2024 Apr; 24(1):145. PubMed ID: 38664624
[TBL] [Abstract][Full Text] [Related]
16. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
17. Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplant According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
Bae JS; Lee DH; Lee SM; Suh KS; Lee KW; Yi NJ; Lee KB; Kim H; Han JK
AJR Am J Roentgenol; 2022 Jul; 219(1):86-96. PubMed ID: 35138137
[No Abstract] [Full Text] [Related]
18. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
[TBL] [Abstract][Full Text] [Related]
19. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.
Halazun KJ; Rosenblatt RE; Mehta N; Lai Q; Hajifathalian K; Gorgen A; Brar G; Sasaki K; Doyle MBM; Tabrizian P; Agopian VG; Najjar M; Ivanics T; Samstein B; Brown RS; Emond JC; Yao F; Lerut J; Rossi M; Mennini G; Iesari S; Finkenstedt A; Schaefer B; Mittler J; Hoppe-Lotichius M; Quintini C; Aucejo F; Chapman W; Sapisochin G
JAMA Surg; 2021 Jun; 156(6):559-567. PubMed ID: 33950167
[TBL] [Abstract][Full Text] [Related]
20. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
